254 related articles for article (PubMed ID: 37138478)
1. Emerging Nanotechnology for the Treatment of Alzheimer's Disease.
Singh A; Ansari VA; Mahmood T; Ahsan F; Wasim R; Maheshwari S; Shariq M; Parveen S; Shamim A
CNS Neurol Disord Drug Targets; 2024; 23(6):687-696. PubMed ID: 37138478
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer's Disease and its Related Dementia Types: A Review on Their Management
Siafaka PI; Mutlu G; Okur NÜ
Curr Alzheimer Res; 2020; 17(14):1239-1261. PubMed ID: 33602090
[TBL] [Abstract][Full Text] [Related]
3. Consequence of Dementia and Cognitive Impairment by Primary Nucleation Pathway.
Singh A; Ansari VA; Ansari TM; Hasan SM; Ahsan F; Singh K; Wasim R; Maheshwari S; Ahmad A
Horm Metab Res; 2023 May; 55(5):304-314. PubMed ID: 37130536
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's Disease and Parkinson's Disease: A Review of Current Treatment Adopting a Nanotechnology Approach.
Trompetero A; Gordillo A; Del Pilar MC; Cristina VM; Bustos Cruz RH
Curr Pharm Des; 2018; 24(1):22-45. PubMed ID: 28847307
[TBL] [Abstract][Full Text] [Related]
5. Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders.
Lipton SA
J Alzheimers Dis; 2004 Dec; 6(6 Suppl):S61-74. PubMed ID: 15665416
[TBL] [Abstract][Full Text] [Related]
6. Carbon Nano Tubes: Novel Drug Delivery System in Amelioration of Alzheimer's Disease.
Mishra J; Kumar B; Pandey M; Pottoo FH; Fayaz F; Khan FA; Sahoo PK
Comb Chem High Throughput Screen; 2021; 24(10):1528-1543. PubMed ID: 32957874
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effect of phytoconstituents via nanotechnology for treatment of Alzheimer diseases.
Paramanick D; Singh VD; Singh VK
J Control Release; 2022 Nov; 351():638-655. PubMed ID: 36191675
[TBL] [Abstract][Full Text] [Related]
9. The Potential Benefits of Nanotechnology in Treating Alzheimer's Disease.
Ling TS; Chandrasegaran S; Xuan LZ; Suan TL; Elaine E; Nathan DV; Chai YH; Gunasekaran B; Salvamani S
Biomed Res Int; 2021; 2021():5550938. PubMed ID: 34285915
[TBL] [Abstract][Full Text] [Related]
10. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
[TBL] [Abstract][Full Text] [Related]
11. Nanotechnology-based drug delivery systems for the treatment of Alzheimer's disease.
Fonseca-Santos B; Gremião MP; Chorilli M
Int J Nanomedicine; 2015; 10():4981-5003. PubMed ID: 26345528
[TBL] [Abstract][Full Text] [Related]
12. Research Progress of Nanocarriers for the Treatment of Alzheimer's Disease.
Li L; Zhang J; Huang X; Du J; Tu Z; Wu H; Liu X; Yuan M
Curr Pharm Des; 2023; 29(2):95-115. PubMed ID: 36529920
[TBL] [Abstract][Full Text] [Related]
13. Dementia of Alzheimer's disease and other neurodegenerative disorders--memantine, a new hope.
Sonkusare SK; Kaul CL; Ramarao P
Pharmacol Res; 2005 Jan; 51(1):1-17. PubMed ID: 15519530
[TBL] [Abstract][Full Text] [Related]
14. Curcumin and Its Derivatives as Theranostic Agents in Alzheimer's Disease: The Implication of Nanotechnology.
Shabbir U; Rubab M; Tyagi A; Oh DH
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375513
[TBL] [Abstract][Full Text] [Related]
15. Advancements in nanotherapeutics for Alzheimer's disease: current perspectives.
Harilal S; Jose J; Parambi DGT; Kumar R; Mathew GE; Uddin MS; Kim H; Mathew B
J Pharm Pharmacol; 2019 Sep; 71(9):1370-1383. PubMed ID: 31304982
[TBL] [Abstract][Full Text] [Related]
16. Role of natural products for the treatment of Alzheimer's disease.
Noori T; Dehpour AR; Sureda A; Sobarzo-Sanchez E; Shirooie S
Eur J Pharmacol; 2021 May; 898():173974. PubMed ID: 33652057
[TBL] [Abstract][Full Text] [Related]
17. Naringenin: A prospective therapeutic agent for Alzheimer's and Parkinson's disease.
Goyal A; Verma A; Dubey N; Raghav J; Agrawal A
J Food Biochem; 2022 Dec; 46(12):e14415. PubMed ID: 36106706
[TBL] [Abstract][Full Text] [Related]
18. Natural Phytochemicals in the Treatment and Prevention of Dementia: An Overview.
Libro R; Giacoppo S; Soundara Rajan T; Bramanti P; Mazzon E
Molecules; 2016 Apr; 21(4):518. PubMed ID: 27110749
[TBL] [Abstract][Full Text] [Related]
19. MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols.
Wilcock D; Jicha G; Blacker D; Albert MS; D'Orazio LM; Elahi FM; Fornage M; Hinman JD; Knoefel J; Kramer J; Kryscio RJ; Lamar M; Moghekar A; Prestopnik J; Ringman JM; Rosenberg G; Sagare A; Satizabal CL; Schneider J; Seshadri S; Sur S; Tracy RP; Yasar S; Williams V; Singh H; Mazina L; Helmer KG; Corriveau RA; Schwab K; Kivisäkk P; Greenberg SM;
Alzheimers Dement; 2021 Apr; 17(4):704-715. PubMed ID: 33480172
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
